NEWSLETTER

The StudySetGo newsletter

Notes from the people running the trials: clinical evidence strategy, regulation, and how health brands use science to win. Written by our team, published on Substack.

LATEST ISSUES

Recent editions

NEWSLETTER
How to make your clinical trials assets and not liabilities

Not all commercial nutrition clinical trials are created equally… and some could even do more harm than good

Read on Substack → 24 Jun 2026
NEWSLETTER
Clinical Evidence Is a Bargaining Chip. Don't Fold It Early.

How (gold-standard) clinical trials can help you get the deal done and be your key to a crazy exit valuation.

Read on Substack → 17 Jun 2026
NEWSLETTER
5 things to know before commissioning your first clinical trial

If you like the idea of becoming a more evidence based brand but you haven't taken the first steps just yet, here are some practical tips to get ready on your e…

Read on Substack → 27 May 2026
NEWSLETTER
How to Commission Clinical Trials that Sell + Increases Valuation

Many clinical trials commissioned by supplement and nutrition brands don’t move the needle, here's how to do it creates ROI.

Read on Substack → 19 May 2026
NEWSLETTER
How to Get an Exit as a Nutrition Brand: Clinical Trials Edition

Why you've been thinking about Clinical Trials the wrong way

Read on Substack → 12 May 2026
NEWSLETTER
What KSM-66 figured out that most supplement brands haven't

People don’t buy on emotion. People don’t buy on evidence either. People buy when they have both. And if your brand only offers one, they’ll go and buy from the…

NEWSLETTER
Your Next Trial Doesn’t Have to Take Three Years

6 to 9 months from first call to published data, stage by stage. What happens in each window. What speeds it up. What causes delays, and how to avoid them.

Read on Substack → 29 Apr 2026
NEWSLETTER
Why decentralised trials now produce better data than the lab

The research model you choose is a commercial decision before it’s a scientific one. Here’s why you should care about the difference.

Read on Substack → 21 Apr 2026
NEWSLETTER
Your Ad Account Doesn’t Have a Copy Problem. It Has an Evidence Problem.

Why Google and Meta suspend supplement ad accounts, and what separates the brands that get pulled from the ones that don't.

Read on Substack → 15 Apr 2026
View all on Substack →

Looking for the practical guides?

Costs, timelines, UK claim regulations, and what retailers require, in plain English.

View the guides →